Syndax Pharmaceuticals Inc
Public company- Headquarters
- NEW YORK, New York
- Ticker
- SNDX
- CIK
- 0001395937
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOKeith A. Goldan | Nov 2, 2026 | Departed |
| principal accounting and financial officer and treasurerAaron A. Ondrey | Nov 2, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- PFIZER INC
CFO appointed: Cecile Guegan
- ROCKET PHARMACEUTICALS, INC.
WARN notice: Cranbury, NJ
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive departure
CFO departs: Keith A. Goldan
Keith A. Goldan, Chief Financial Officer, principal accounting and financial officer and treasurer of Syndax Pharmaceuticals Inc, retires the role, effective November 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 2, 2026Role: Chief Financial Officer, principal accounting and financial officer and treasurer
- Executive appointment
principal accounting and financial officer and treasurer appointed: Aaron A. Ondrey
Aaron A. Ondrey was named principal accounting and financial officer and treasurer of Syndax Pharmaceuticals Inc. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 2, 2026Role: principal accounting and financial officer and treasurer
Last verified Nov 8, 2026